Substituted N′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors
Disclosed herein is a compound of formula (I), or a pharmaceutically acceptable salt thereof. Also disclosed herein are uses of the compounds disclosed herein in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising a compound disclosed herein. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.
Merck Sharp & Dohme Corp.
A A C C
A61P A61P C07D C07D
inventional inventional inventional inventional
Derun Hongjun Guoqing Kun Abdelghani Joseph Yongxin Qinglin Shuwen Liangqin Wensheng Ravi
Li Zhang Li Liu Achab Kozlowski Han Pu He Guo Yu Nargund